Both atherosclerosis and obesity, an independent atherosclerotic risk factor, are associated with enhanced systemic inflammation. Obesity is also characterized by increased adipose tissue inflammation. However, the molecular mechanism underlying the accelerated atherosclerosis in obesity remains unclear. In obesity, activation of c-Jun N-terminal kinase (JNK) contributes to adipose tissue inflammation. The present study investigated whether the suppression of fat inflammation through adipose-specific JNK inactivation could protect against atherosclerosis in mice. ApoE−/− mice were cross-bred with transgenic mice with adipose-specific expression of a dominant negative form of JNK (dnJNK) to generate apoE−/−/dnJNK (ADJ) mice. ADJ mice treated with a high-fat–high-cholesterol diet exhibited significant attenuations of visceral fat and systemic inflammation without changes in lipid or glucose metabolism, and were protected against atherosclerosis, when compared with apoE−/− mice. Lean apoE−/− mice that received transplantation of visceral fat from obese wild-type donor mice for 4 weeks showed exacerbated systemic inflammation and atherosclerotic plaque formation. Conversely, apoE−/− recipients carrying a visceral fat graft from obese dnJNK donors were protected against enhanced systemic inflammation and atherogenesis. The beneficial effects of adipose-specific JNK inactivation on atherogenesis in apoE−/− recipients were significantly compromised by continuous infusion of recombinant adipocyte–fatty acid-binding protein (A-FABP), previously shown to interact with JNK via a positive feedback loop to modulate inflammatory responses. Together these data suggested that enhanced atherosclerosis in obesity can be attributed, at least in part, to a distant cross-talk between visceral fat and the vasculature, mediated by the release of proinflammatory cytokines, such as A-FABP, from the inflamed visceral adipose tissue with JNK activation.
Article navigation
Research Article|
October 11 2016
Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice
Kelvin H.M. Kwok
;
Kelvin H.M. Kwok
*
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, 999077 Hong Kong†
Department of Medicine, University of Hong Kong, 999077 Hong Kong, China
Search for other works by this author on:
Kenneth K.Y. Cheng
;
Kenneth K.Y. Cheng
*
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, 999077 Hong Kong†
Department of Medicine, University of Hong Kong, 999077 Hong Kong, China
Search for other works by this author on:
Ruby L.C. Hoo
;
Ruby L.C. Hoo
*
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, 999077 Hong Kong†
Department of Medicine, University of Hong Kong, 999077 Hong Kong, China
Search for other works by this author on:
Dewei Ye
;
Dewei Ye
*
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, 999077 Hong Kong†
Department of Medicine, University of Hong Kong, 999077 Hong Kong, China
Search for other works by this author on:
Aimin Xu
;
*
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, 999077 Hong Kong†
Department of Medicine, University of Hong Kong, 999077 Hong Kong, China‡
Research Centre for Heart, Brain, Hormones and Healthy Aging, University of Hong Kong, 999077 Hong Kong§
Department of Pharmacology and Pharmacy, University of Hong Kong, 999077 Hong Kong
Correspondence: Karen S.L. Lam (email ksllam@hku.hk) or Aimin Xu (email amxu@hku.hk).
Search for other works by this author on:
Karen S.L. Lam
*
State Key Laboratory of Pharmaceutical Biotechnology, University of Hong Kong, 999077 Hong Kong†
Department of Medicine, University of Hong Kong, 999077 Hong Kong, China‡
Research Centre for Heart, Brain, Hormones and Healthy Aging, University of Hong Kong, 999077 Hong Kong
Correspondence: Karen S.L. Lam (email ksllam@hku.hk) or Aimin Xu (email amxu@hku.hk).
Search for other works by this author on:
Clin Sci (Lond) (2016) 130 (22): 2087-2100.
Article history
Received:
June 22 2016
Revision Received:
August 04 2016
Accepted:
August 10 2016
Accepted Manuscript online:
August 10 2016
Connected Content
This is a commentary on:
Adipose inflammation at the heart of vascular disease
Citation
Kelvin H.M. Kwok, Kenneth K.Y. Cheng, Ruby L.C. Hoo, Dewei Ye, Aimin Xu, Karen S.L. Lam; Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice. Clin Sci (Lond) 1 November 2016; 130 (22): 2087–2100. doi: https://doi.org/10.1042/CS20160465
Download citation file:
Close
Sign in
Don't already have an account? Register
Sign in to your personal account
You could not be signed in. Please check your email address / username and password and try again.
Biochemical Society Member Sign in
Sign InSign in via your Institution
Sign in via your InstitutionCited By
Related Articles
Adipose tissue inflammation and insulin resistance: all obese humans are not created equal
Biochem J (August, 2010)
Fatty Acid Synthesis De Novo in Human Adipose Tissue
Clin Sci Mol Med (April, 1974)
Peroxisome-proliferator-activated receptor δ mediates the effects of long-chain fatty acids on post-confluent cell proliferation
Biochem J (August, 2000)
The forgotten face of regular physical exercise: a ‘natural’ anti-atherogenic activity
Clin Sci (Lond) (April, 2011)